Overview
Pritha Sen is an Infectious Disease provider in Boston, Massachusetts. Dr. Sen has been practicing medicine for over 18 years and is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are COVID-19, Severe Acute Respiratory Syndrome (SARS), and Cytomegalovirus Infection.
Her clinical research consists of co-authoring 23 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 9 articles in the study of COVID-19.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
Locations
75 Francis St, Boston, MA 02115
55 Fruit St, Boston, MA 02114
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Eirini Christaki is an Infectious Disease provider in Providence, Rhode Island. Dr. Christaki is rated as a Distinguished provider by MediFind in the treatment of COVID-19. Her top areas of expertise are COVID-19, Flu, Sepsis, and Pneumonia.
Dana-Farber Cancer Institute, Inc.
Lindsey Baden is an Infectious Disease provider in Boston, Massachusetts. Dr. Baden is rated as a Distinguished provider by MediFind in the treatment of COVID-19. His top areas of expertise are COVID-19, Severe Acute Respiratory Syndrome (SARS), Pneumonia, and HIV/AIDS. Dr. Baden is currently accepting new patients.
Brigham And Womens Physicians Organization Inc
Dr. Li is an infectious disease physician-scientist at the Brigham and Women’s Hospital and Harvard Medical School. He leads an active clinical and translational laboratory research program focused on viral detection, reservoirs and resistance, especially within the fields of HIV and COVID-19.Dr. Li is the Director of the Harvard/Brigham Virology Specialty Laboratory, the Director of the Harvard University Center for AIDS Research Clinical Core, and a member of the AIDS Clinical Trials Group (ACTG) Executive Committee. He is the protocol co-Chair of the ACTG A5308 study of ART treatment for HIV-1 controllers, the co-Chair of the A5345 study of biomarkers of HIV rebound, and the protocol virologist for A5401/ACTIV-2 Adaptive Platform Treatment Trial for Outpatients with COVID-19. Dr. Li also serves as the Deputy Editor for the Infectious Disease Society of America (IDSA) journal Open Forum Infectious Diseases and on the Editorial Advisory Board for the Journal of Infectious Diseases. Dr. Li is rated as a Distinguished provider by MediFind in the treatment of COVID-19. His top areas of expertise are HIV/AIDS, COVID-19, Sepsis, Prostatectomy, and Nephrectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- COVID-19Dr. Sen isAdvanced. Learn about COVID-19.
- Experienced
- Cytomegalovirus InfectionDr. Sen isExperienced. Learn about Cytomegalovirus Infection.
- Severe Acute Respiratory Syndrome (SARS)